Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Not effective COMMISSION DECISION of 21 June 2012 appointing independent scientific experts to the Pharmacovigilance Risk Assessment Committee (Text with EEA relevance)

Rozhodnutie č. 622/2012

Text language

Important dates

Declared: 21. júna 2012
Approved: 21. júna 2012
Effective from: 2. júla 2012
Effective until: 2. júla 2015

Documents and links

COMMISSION DECISION

of 21 June 2012

appointing independent scientific experts to the Pharmacovigilance Risk Assessment Committee

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (1), and in particular Article 61a(1) thereof,

Whereas:

(1)

Article 61a(1) of Regulation (EC) No 726/2004 requires that the Commission appoints six independent scientific experts as members of the Pharmacovigilance Risk Assessment Committee.

(2)

Article 61a(1) of Regulation (EC) No 726/2004 provides that the Commission is to appoint those members with a view to ensuring that the relevant expertise is available within the Committee.

(3)

In accordance with Article 61a(1) of Regulation (EC) No 726/2004, a public call for expression of interest has been undertaken by the Commission.

(4)

The members of the Committee are to be appointed for a period of three years starting on 2 July 2012, which may be prolonged once.

(5)

Where an independent scientific expert appointed by this decision is no longer capable of contributing efficiently to the work of the Committee, or resigns, the Commission may replace this member from the reserve list, for the remaining duration of the member’s mandate,

HAS ADOPTED THIS DECISION:

Article 1

The following are hereby appointed members of the Pharmacovigilance Risk Assessment Committee for a term of three years from 2 July 2012:

—

Jane Ahlqvist RASTAD,

—

Marie Louise DE BRUIN,

—

Stephen J. W. EVANS,

—

Brigitte KELLER-STANISLAWSKI,

—

Hervé LE LOUET,

—

Lennart WALDENLIND.

Article 2

The following are hereby placed on a reserve list by order of merit:

—

Thierry TRENQUE,

—

Michael THEODORAKIS,

—

Giampiero MAZZAGLIA,

—

Marie-Christine PERAULT-POCHAT,

—

Annemarie HVIDBERG HELLEBEK.

Done at Brussels, 21 June 2012.

For the Commission

John DALLI

Member of the Commission

Poznámky